Related references
Note: Only part of the references are listed.4-Methylumbelliferone inhibits tumour cell growth and the activation of stromal hyaluronan synthesis by melanoma cell-derived factors
M. Edward et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Antitumor Activity of Hyaluronic Acid Synthesis Inhibitor 4-Methylumbelliferone in Prostate Cancer Cells
Vinata B. Lokeshwar et al.
CANCER RESEARCH (2010)
Hyaluronan Deficiency in Tumor Stroma Impairs Macrophage Trafficking and Tumor Neovascularization
Nobutaka Kobayashi et al.
CANCER RESEARCH (2010)
Deficiency in the Serum-Derived Hyaluronan-Associated Protein-Hyaluronan Complex Enhances Airway Hyperresponsiveness in a Murine Model of Asthma
Long Zhu et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2010)
Hyaluronan Stabilizes Focal Adhesions, Filopodia, and the Proliferative Phenotype in Esophageal Squamous Carcinoma Cells
Soeren Twarock et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3
Anne Kultti et al.
EXPERIMENTAL CELL RESEARCH (2009)
The effects of 4-methylumbelliferone on hyaluronan synthesis, MMP2 activity, proliferation, and motility of human aortic smooth muscle cells
Davide Vigetti et al.
GLYCOBIOLOGY (2009)
Pericellular Matrix Formation Alters the Efficiency of Intracellular Uptake of Oligonucleotides in Osteosarcoma Cells
Yoshitaka Suzuki et al.
JOURNAL OF SURGICAL RESEARCH (2009)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44
Roozbeh Golshani et al.
CANCER RESEARCH (2008)
Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression
Lilly Y. W. Bourguignon
SEMINARS IN CANCER BIOLOGY (2008)
Hyaluronan oligosaccharides sensitize lymphoma resistant cell lines to vincristine by modulating P-glycoprotein activity and PI3K/Akt pathway
Rosalia I. Cordo Russo et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Hyaluronan-induced masking of ErbB2 and CD44-enhanced trastuzumab internalisation in trastuzumab resistant breast cancer
Zsuzsanna Palyi-Krekk et al.
EUROPEAN JOURNAL OF CANCER (2007)
Hyaluronan oligosaccharides inhibit tumorigenicity of osteosarcoma cell lines MG-63 and LM-8 in vitro and in vivo via perturbation of hyaluronan-rich pericellular matrix of the cells
Kozo Hosono et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells
Yuejuan Li et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells
Sara R. Hamilton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Estimates of the cancer incidence and mortality in Europe in 2006
J. Ferlay et al.
ANNALS OF ONCOLOGY (2007)
Clinical management of women with metastatic breast cancer: a descriptive study according to age group
Klaartje Manders et al.
BMC CANCER (2006)
The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer
L Udabage et al.
EXPERIMENTAL CELL RESEARCH (2005)
Anti sense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer
L Udabage et al.
CANCER RESEARCH (2005)
Antisense inhibition of hyaluronan synthase-2 in human osteosarcoma cells inhibits hyaluronan retention and tumorigenicity
Y Nishida et al.
EXPERIMENTAL CELL RESEARCH (2005)
Neoadjuvant versus adjuvant systemic treatment in breast cancer: A meta-analysis
D Mauri et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Health-related quality of life among patients with breast cancer receiving zoledronic acid or pamidronate disodium for metastatic bone lesions
KP Weinfurt et al.
MEDICAL CARE (2004)
A novel mechanism for the inhibition of hyaluronan biosynthesis by 4-methylumbelliferone
I Kakizaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44
HR Kim et al.
CANCER RESEARCH (2004)
The hyaluronan synthesis inhibitor 4-methylumbelliferone prevents keratinocyte activation and epidermal hyperproliferation induced by epidermal growth factor
K Rilla et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
A study of inter-alpha-trypsin inhibitor chains expression in liposarcomas
I Tabata et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2003)
Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (Macrophage-Colony stimulating factor) production and breast tumor progression
LYW Bourguignon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Changed lamellipodial extension, adhesion plaques and migration in epidermal keratinocytes containing constitutively expressed sense and antisense hyaluronan synthase 2 (Has2) genes
K Rilla et al.
JOURNAL OF CELL SCIENCE (2002)
Inhibition of prostate tumor cell hyaluronan synthesis impairs subcutaneous growth and vascularization in immunocompromised mice
MA Simpson et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Signaling properties of hyaluronan receptors
EA Turley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
CD44-mediated uptake and degradation of hyaluronan
W Knudson et al.
MATRIX BIOLOGY (2002)
Hyaluronan enters keratinocytes by a novel endocytic route catabolism
R Tammi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer
P Lipponen et al.
EUROPEAN JOURNAL OF CANCER (2001)
Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival
P Auvinen et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
